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ABSTRACT
Respiratory syncytial virus (RSV) is one of the leading
causes of bronchiolitis in children, and severe RSV
infection early in life has been associated with asthma
development. Using a neonatal mouse model, we have
shown that down-regulation of IL-4 receptor a (IL-4Ra)
with antisense oligonucleotides in the lung during neo-
natal infection protected from RSV immunopathophysi-
ology. Significant down-regulation of IL-4Ra was
observed on pulmonary CD11b+ myeloid dendritic cells
(mDCs) suggesting a role for IL-4Ra on mDCs in the
immunopathogenesis of neonatal RSV infection. Here,
we demonstrated that neonatal CD11b+ mDCs expressed
higher levels of IL-4Ra than their adult counterparts.
Because CD11b+ mDCs mainly present antigens to CD4+
T cells, we hypothesized that increased expression of IL-
4Ra on neonatal CD11b+ mDCs was responsible for Th2 -
biased RSV immunopathophysiology. Indeed, when
IL-4Ra was selectively deleted from CD11b+ mDCs, the
immunopathophysiology typically observed following
RSV reinfection was ablated, including Th2 inflammation,
airway-mucus hyperproduction, and pulmonary dys-
function. Further, overexpression of IL-4Ra on adult
CD11b+ DCs and their adoptive transfer into adult mice
was able to recapitulate the Th2-biased RSV immuno-
pathology typically observed only in neonates infected
with RSV. IL-4Ra levels on CD11c+ cells were inversely
correlated with maturation status of CD11b+ mDCs upon
RSV infection. Our data demonstrate that developmen-
tally regulated IL-4Ra expression is critical for the
maturity of pulmonary CD11b+ mDCs and the Th2-biased
immunopathogenesis of neonatal RSV infection.
J. Leukoc. Biol. 102: 153–161; 2017.
Introduction
RSV causes acute lower respiratory tract infections in infants,
and it is the leading cause of bronchiolitis in children under
one year of age [1, 2]. RSV infection severe enough to require
hospitalization during infancy is associated with increased risk
of wheezing and development of asthma [3, 4]. Currently, no
effective vaccines or therapeutics for RSV exist. The develop-
ment of such products is partially hindered by our lack of
knowledge of the infant immune system and its response to RSV
infection.
RSV infection in infants induces a Th2-biased immune response,
which is partly responsible for RSV pathogenesis [5, 6]. A study
comparing cytokine levels in the serum of RSV- vs. influenza-
infected infants found higher concentrations of Th2 cytokines
(IL-4 and IL-5) in RSV-infected children, suggesting that the Th2-
biased response is not simply an age-specific response but also a
virus-specific response [7]. Animal studies have reported similar
findings [8, 9]. Age at initial RSV infection is important in
determining the Th2 bias [10]; infection of neonatal mice and
reinfection upon adulthood induces a Th2-biased immune re-
sponse leading to Th2 cytokines (IL-4, IL-5, and IL-13), airway
remodeling, mucus hyperproduction, and airway hyperreactivity
[9–12]. Further, polymorphisms in IL-4Ra have been associated
with RSV disease severity [13]. We have previously shown that
down-regulation of IL-4Ra with antisense oligonucleotide during
primary RSV infection in neonatal mice mitigated Th2-biased
immunopathophysiologies upon reinfection [12], which raises the
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intriguing possibility that IL-4Ra has a role in the immunopatho-
genesis of neonatal RSV infection.
DCs are APCs that initiate and dictate the ensuing adaptive
immune response after exposure to a pathogen. DCs are
functionally divided into two main classes: mDCs and pDCs.
mDCs present Ags to T cells and help T cells to differentiate [14],
whereas pDCs produce type I IFNs to combat viral infection [15].
mDCs are further classified into CD11b+ mDCs, which mainly
present Ags to CD4+ T cells [16, 17], and CD103+ mDCs, which
mainly cross-present Ags to CD8+ T cells [16]. Several functional
and phenotypic differences have been shown between neonatal
and adult DCs [18–20]. Additionally, RSV infection induces
significantly less recruitment of pDCs and, thus, type I IFNs in the
lung of neonatal vs. adult mice [21]; pDCs from cord blood
express lower levels of type I IFNs compared with pDCs from
adult peripheral blood in response to RSV stimulation ex vivo
[22]. Neonatal mDCs express lower levels of costimulatory
molecules (CD80 and CD86) and produce less IL-12 (a Th1
cytokine) in response to LPS compared with their adult
counterparts [18, 19].
In the present study, we demonstrated an age-dependent
expression of IL-4Ra on pulmonary DCs. Neonatal CD11b+
mDCs (CD11c+ MHCII+ CD11b+) and pDCs (CD11c+ PDCA-1+)
expressed higher levels of IL-4Ra compared with their adult
counterparts, whereas neonatal CD103+ mDCs (CD11c+ MHCII+
CD103+) expressed less IL-4Ra than they did in adults. Because
the age at initial infection is important in determining the Th2-
biased immune response to RSV infection [9, 10, 23] and
CD11b+ mDCs are mainly responsible for Ag presentation and
activation of CD4+ T cells [16, 17], we hypothesized that the
elevated expression of IL-4Ra on neonatal mDCs is responsible
for the Th2-biased immunopathogenesis of neonatal RSV
infection. To test that hypothesis, we infected mice deficient in
IL-4Ra CD11b+ mDCs [24] and evaluated the Th2-biased
immune response to RSV in vitro and in vivo. Furthermore, we
adoptively transferred mDCs that overexpressed IL-4Ra into
adult mice to confirm the importance of IL-4Ra in the induction
of Th2-biased immune responses to RSV. Our data demonstrate
that high levels of IL-4Ra, as occurs in infancy, inhibit the
maturation of CD11b+ mDCs, and, for the first time to our
knowledge, our data establish a critical role for IL-4Ra on
CD11b+ mDCs in initiating the Th2-biased immunopathogenesis
of neonatal RSV infection.
MATERIALS AND METHODS
Mice
BALB/c mice were purchased from Envivo (Cambridgeshire, United
Kingdom) and were housed in a specific pathogen-free animal facility at the
University of Tennessee Health Science Center (Memphis, TN, USA). CD11c-
specific IL-4Ra2/2 mice (IL-4Ra2/2DC) or their littermates (IL-4Ra2/loxDC)
were generated by crossing IL-4Ralox/lox mice with CD11ccre IL-4Ra2/2 mice
(gifts from Frank Brombacher, University of Cape Town, Cape Town, South
Africa and were generously donated by Debroski Herbert, University of
California, San Francisco, CA, USA) [24]. All mice were on BALB/c
background. Breeders were time mated, and age-matched pups were used for
all experiments. All animal experiments were performed according to
Guidelines of Care and Use of Laboratory Animals and approved by University
of Tennessee Health Science Center Animal Care and Use Committee.
Experimental design and RSV infection
Neonatal (5 d old) or adult mice (6 wk old) were infected intranasally
with human RSV strain A-2 (2 3 105 50% tissue culture infective dose
(TCID50)/g body weight; Advanced Biotechnologies, Eldersburg, MD,
USA) in 10 ml (neonates) or 50 ml (adults) of SFM (GE Healthcare Life
Sciences, Little Chalfont, United Kingdom) or SFM alone (sham). A
subset of the cohort was allowed to mature and was reinfected 4 wk later.
At 6 d after reinfection, various endpoints were measured, including
lung function and histopathology, BALF cytokines or cellularity, and
T cell profile.
BMDCs transduction and transfer
Bone marrow cells were isolated from the tibia and femur of adult mice (5–7 wk
old) mice, as previously described [25] and then cultured in DC media
(RPMI 1640; GE Healthcare Life Sciences) supplemented with 10% heat-
inactivated FBS (Thermo Fisher Scientific, Waltham, MA, USA), 100 U/ml
penicillin (GE Healthcare Life Sciences), 100 mg/ml streptomycin (GE
Healthcare Life Sciences) human FLT3 200 ng/ml (Tonbo Biosciences, San
Diego, CA, USA) for 6 d at a density of 1 3 106/ml in a 6-well plate [26].
BMDCs were then harvested and infected with third-generation lentiviral
vectors (pLV-IL-4Ra-eGFP or control pLV-eGFP) (Cyagen Biosciences, Santa
Clara, CA, USA) at a multiplicity of infection 20 in Opti-MEM media (Thermo
Fisher Scientific) and 5 mg/ml of polybrene (Cyagen Biosciences) for 3 h.
These cells were cultured in DC medium for 4 d. Transduced cells were then
infected with RSV at a multiplicity of infection 50 overnight, and CD11b+
mDCs that were positive for eGFP were sorted with a SH800 cell sorter (Sony
Biotechnology, San Jose, CA, USA). These cells were adoptively transferred
intranasally into the lungs of mice (1 3 105 cells in 50 ml of SFM media).
Control mice received 50 ml of SFM media.
RSV gene expression in the lung
RSV gene expression in the lungs was quantified using real-time RT-PCR that
correlates well with a plaque assay or TCID50 assay [9, 21, 27]. Lungs were
isolated, and total RNA was extracted using the Total RNA extraction kit
(Qiagen, Valencia, CA, USA) according to the manufacturer’s instructions.
cDNA was synthesized using Oligo (dT) and SuperScript III first-strand
synthesis system (Thermo Fisher Scientific). Real-time PCR was
performed using Platinum SYBR Green qPCR Supermix (Thermo
Fisher Scientific) with the following primers: NS1 forward primer
(59-CACAACAATGCCAGTGCTACAA-39) and NS1 reverse primer
(59-TTAGACCATTAGGTTGAGAGCAATGT-39).
Cell staining and flow cytometry
To measure the expression of surface markers on pulmonary DCs, single-cell
suspensions were prepared from mouse lungs using gentleMACS Octo
Dissociator (Miltenyi Biotec, San Diego, CA, USA), as previously reported
[21]. Single cells were then stained with fixable viability dyes, Abs to CD11c
(N418), CD11b (M1/70; BioLegend, San Diego, CA, USA), CD103 (2E7),
PDCA-1 (eBio 927; eBioscience, San Diego, CA, USA), and either IL-4Ra
(mIL-4R-M1; BD Biosciences, San Jose, CA, USA) or MHCII (M5/114.15.2),
CD80 (16-10A1), and CD86 (GL-1). All Abs and dyes were from eBioscience
unless otherwise stated. The staining data were acquired on a FACS Canto II
(BD Biosciences) flow cytometer and analyzed with FlowJo software (version
10; Tree Star; Ashland, OR, USA.). Because the MFI of IL-4Ra FMO controls
were different among the mice at different ages (i.e., 1 d, 5 d, and 6 wk), the
IL-4Ra MFI was normalized by subtracting the MFI of the age-matched FMO
controls from the actual values.
(continued from previous page)
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To measure the T cell profile in the lung, single cells from lungs were
isolated as mentioned and stimulated for 5 h at 37°C in RPMI 1640,
containing 10% heat-inactivated FBS (Thermo Fisher Scientific), 100 U/ml
penicillin (GE Healthcare), 100 mg/ml streptomycin (GE Healthcare), 5 ng/ml
PMA (Sigma-Aldrich; St. Louis, MO, USA), 500 ng/ml ionomycin (Sigma-
Aldrich), and protein transport inhibitor (1 ml/106 cells; GolgiPlug, BD
Biosciences). Cells were then stained with fixable viability dye, fixed with
fixation buffer, permeabilized with permeabilization buffer, and labeled with
Abs to CD3 (17A2), CD4 (RM4-5; BioLegend), IFN-g (XMG1.2), and IL-4
(BVD6-24G2). All Abs, dyes, and buffers were from eBioscience unless
otherwise stated. Flow data were then acquired and analyzed as described.
Cells were gated on lymphocytes based on forward and side scatter light
properties, singlets, and live cells and then on the CD3 and CD4 double-
positive population.
BALF cellularity
BALF was isolated with 1 ml of PBS and 0.5% BSA; 20,000 cells from
BALF were centrifuged onto slides and stained with a Hema-3 staining kit
(Thermo Fisher Scientific). Cells were then differentiated and counted
by one unbiased observer using an EVOS microscope (Thermo Fisher
Scientific).
Pulmonary function test
Airway resistance was assessed with the FlexiVent FX system (Scireq,
Montreal, QC, Canada) to increasing doses of methacholine (Sigma-
Aldrich). Mice were anesthetized with ketamine/xylazine (180/10 mg/kg)
and mechanically ventilated at a tidal volume of 10 ml/kg and a frequency
of 2.5 Hz, using a computer-controlled piston ventilator. Resistance was
calculated by recording pressure and volume in the airways using the
single-compartment model. All data were normalized to their individual
baseline resistance values [(Value 2 baseline)/Baseline] and plotted as
normalized resistance.
Lung histopathology
After euthanasia, hearts of mice were perfused with PBS, and lungs were
removed and gravity inflated with zinc formalin (Thermo Fisher Scientific)
and then fixed for 24 h. Lung tissues were then embedded in paraffin,
sectioned, and stained with H&E or PAS. Stained lung sections were visualized,
and images acquired with an EVOS microscope. Inflammation was semi-
quantitatively scored in a blinded fashion based on the following scale: 1, very
mild; 2, mild; 3, moderate; and 4, severe. PAS staining was scored by a
quantitative method [28].
Cytokines in the lung
Cytokine levels, including IL-4, IL-12 (p40), and IFN-g, were measured in the
BALF with a Milliplex kit (EMD Millipore, Billerica, MA, USA) and a Luminex
system (Luminex, Austin, TX, USA), per the manufacturer’s instruction.
Each sample was analyzed in duplicate. IL-13 in the lung homogenates was
quantified with a mouse IL-13 Platinum ELISA kit (eBioscience). The
detection limits for IL-4, IL-12 (p40), IFN-g, and IL-13 were 0.4, 4.9, 0.9, and
2.8 pg/ml, respectively.
In vitro T cell activation assay
Pulmonary CD11b+ mDCs (CD11c+MHCII+CD11b+) were isolated first with
the CD11c Positive Selection Kit (StemCell Technologies, Vancouver, BC,
Canada) and then with an SH800 cell sorter (Sony Biotechnology) from lungs
of neonatal mice at 6 d after infection with RSV. CD4+ T cells were isolated
from the spleen of naı̈ve adult BALB/c mice with a CD4 positive selection kit
(StemCell Technologies) and stained with 0.5 mM CFSE (Thermo Fisher
Scientific). CFSE-stained CD4+ cells (1 3 105) were then cocultured with
CD11b+ mDCs (2 3 104) in the presence of 1 mg/ml CD3 Ab (17A2;
eBioscience) for 72 h. Cells were stimulated, stained, and analyzed by flow
cytometry to determine the Th subpopulations. The purity of isolated CD11b+
mDCs or CD4+ cells was .90 percent.
Statistical analyses
Data were plotted as means 6 SEM and analyzed using GraphPad Prism 6
(GraphPad, La Jolla, CA, USA). Student’s t test or 2-way ANOVA with Bonferroni
post hoc tests were used to compare the means among groups, where
appropriate. Differences were considered statistically significant at P , 0.05.
RESULTS
Expression of IL-4Ra on DCs was age dependent
In our previous study [12], we observed that the most significant
down-regulation of IL-4Ra after antisense oligonucleotide
treatment occurred in pulmonary DCs, and that down-regulation
correlated with decreased Th2-biased immunopathologies
during RSV reinfection, suggesting a role for IL-4Ra on DCs
in RSV immunopathogenesis [12]. To explore that possibility,
we first quantified IL-4Ra expression on various types of
pulmonary DCs from mice at different ages (gating strategy in
Supplemental Fig. 1). Specifically, we measured expression of
IL-4Ra on pulmonary CD11b+ mDCs (CD11c+MHCII+CD11b+),
CD103+ mDCs (CD11c+MHCII+CD103+), and pDCs (CD11c+
PDCA-1+) from neonatal (1 or 5 d old) or adult mice (6 wk old)
via flow cytometry (Fig. 1A). The expression of IL-4Ra on
CD11b+ mDCs declined as age increased, with 1-d-old pups
expressing the greatest amount (Fig. 1B). Interestingly, IL-4Ra
expression on CD103+ mDCs increased with age, with adults
expressing the greatest amount (Fig. 1C). Similar to CD11b+
mDCs, pDCs down-regulated IL-4Ra expression as age in-
creased (Fig. 1D). These data suggest that the expression of
IL-4Ra on pulmonary DCs is developmentally regulated and
cell specific.
Deletion of IL-4Ra on CD11c+ cells attenuated Th2-
biased immune responses upon RSV reinfection
Having confirmed that neonatal CD11b+ mDCs express elevated
levels of IL-4Ra, we further examined the role of IL-4Ra on
CD11b+ mDCs in polarizing the Th2-biased immune response to
RSV. We used a mouse model in which IL-4Ra is specifically
deleted on CD11c+ cells (IL-4Ra2/2DC) by crossing IL-4Ralox/lox
mice with CD11cCre IL-4Ra2/2 mice [24]. In IL-4Ra2/2DC mice,
the expression of IL-4Ra is decreased on CD11b+ mDCs, CD103+
mDCs, and alveolar macrophages but not on T cells (Supple-
mental Fig. 2). The littermate controls (IL-4Ra2/loxDC) have 1
copy of intact Il-4Ra. IL-4Ra2/2DC and IL-4Ra2/loxDC neonatal
mice were infected with RSV (IL-4Ra2/2DCRR and IL-4Ra2/loxDCRR)
or medium (IL-4Ra2/2DCsham or IL-4Ra2/loxDCsham) at 5 d of
age and reinfected with RSV 4 wk later. At 6 d after reinfection,
we analyzed the CD4+ T cell responses from the lungs of those
mice. As expected, the IL-4Ra2/loxDCRR mice that had one
copy of intact Il-4Ra mounted a Th2-biased immune response
upon RSV reinfection, although the magnitude of this Th2 bias
was smaller than in BALB/c mice, as we previously published
[12]. Importantly, we observed a significant decrease in the
percentage of CD4+ IL-4+ T cells in the IL-4Ra2/2DCRR mice
compared with the IL-4Ra2/loxDCRR mice (Fig. 2A). There was
also reduction in CD4+ IFN-g+ IL-4+ T cells in IL-4Ra2/2DC RR
mice vs. IL-4Ra 2/loxDCRR mice (Fig. 2A). This reduction in
Th2 cells was accompanied by a decrease in IL-13 (Table 1) in
Shrestha et al. IL-4Ra on dendritic cells in RSV infection
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lung homogenates after RSV reinfection; in fact, IL-13 levels
in lung homogenates were similar to uninfected groups
(IL-4Ra2/2DCsham or IL-4Ra2/loxDCsham). IL-4 was very low in
all groups and below the limit of detection in the uninfected
groups. Although no difference was observed in the percentage
of CD4+ IFN-g+ T cells between the RSV-infected groups, we
did observe an elevation in IL-12p40 levels in the BALF of
IL-4Ra2/2DCRR mice vs. IL-4Ra2/loxDCRR (Table 1). These
results were not due to a difference in relative viral gene
expression of RSV (Fig. 2B) or baseline numbers of DCs during
initial infection (Supplemental Fig. 3). These data indicate that
IL-4Ra on CD11b+ mDCs has a role in the Th2-biased immune
response to neonatal RSV infection in vivo.
Deletion of IL-4Ra on CD11c+ cells protected mice
from immunopathophysiology upon RSV reinfection
In addition to the pulmonary CD4+ T cell responses, we also
examined pathophysiologic endpoints, including BALF cellular-
ity and pulmonary function and pathology in IL-4Ra2/2DCRR
and IL-4Ra2/loxDCRR mice. We observed substantially reduced
inflammatory responses in the airways of IL-4Ra2/2DCRR mice,
as evidenced by reduced total cells, macrophages, and
eosinophils in the BALF compared with IL-4Ra2/loxDCRR mice
(Fig. 3A). As shown in Fig. 3B, RSV-induced airway hyperreac-
tivity in IL-4Ra2/loxDCRR mice, whereas airway resistance in IL-
4Ra2/2DCRR mice was no different than that of the sham controls.
No significant differences in resistance were detected between
groups of sham-infected mice. Peribronchiolar and perivascular
inflammation was significantly reduced in IL-4Ra2/2DCRR vs.
IL-4Ra2/loxDCRR mice (Fig. 3C). Strikingly, there was little-to-no
mucus production in the airways of IL-4Ra2/2DCRR, whereas
significant amounts of airway mucus were obvious in IL-4Ra2/loxDCRR
mice (Fig. 3D). That observation is consistent with the fact that
airway resistance in IL-4Ra2/2DCRR mice was no different from
that of sham-infected mice. The decrease in airway inflamma-
tion, airway hyperreactivity, and mucus hyperproduction in
IL-4Ra2/2DCRR mice suggests that elevated IL-4Ra expression
on CD11b+ mDCs is partially responsible for the immunopa-
thophysiology upon RSV reinfection.
Absence of IL-4Ra on CD11b+ mDCs dampened Th2
responses to RSV infection in vitro
Although the expression of IL-4Ra decreased in neonatal
CD11b+ mDCs in the IL-4Ra2/2DC mice, it was also decreased in
Figure 1. Expression of IL-4Ra on DCs was age dependent. Lung DCs from neonatal (1 or 5 d old) or adult (6 wk old) mice were analyzed by flow
cytometry for the surface expression of IL-4Ra. (A) Flow cytometric histogram graphs show a representative example of IL-4Ra expression on DC
subsets. (B) IL-4Ra MFI on CD11b+ mDCs. (C) IL-4Ra MFI on CD103+ mDCs. (D) IL-4Ra MFI on pDCs. Shaded histograms represent FMO
controls. Data are representative of 3 independent experiments with 4–5 mice/group. *P , 0.05.
156 Journal of Leukocyte Biology Volume 102, July 2017 www.jleukbio.org
CD103+ mDCs and alveolar macrophages (Supplemental Fig.
2). To examine the role of IL-4Ra specifically on CD11b+
mDCs to induce a Th2-biased immune response to RSV, we
performed in vitro T cell–activation assays. Pulmonary CD11b+
mDCs were isolated from RSV-infected neonatal IL-4Ra2/2DC
or IL-4Ra2/loxDC mice. Those cells were subsequently cocul-
tured for 3 d with splenic CD4+ T cells isolated from naı̈ve
adult BALB/c mice, and T cell phenotypes were then
measured by flow cytometry. As expected, neonatal CD11b+
mDCs from IL-4Ra2/loxDC mice induced a substantial amount
of Th2 cells (CD4+IL-4+), and mimicking our in vivo data,
CD11b+ mDCs from IL-4Ra2/2DC mice induced significantly
less Th2 cells and a decreased ratio of Th2/Th1 (CD4+IL-4+/
CD4+IFN-g+) cells (Fig. 4). These data suggest that IL-4Ra
expression on CD11b+ mDCs promotes Th2-biased immune
responses to RSV.
Loss of IL-4Ra expression on CD11b+ mDCs enhanced
their maturation response to RSV
To delineate the mechanism by which IL-4Ra on CD11b+ mDCs
induced Th2-biased responses to RSV in neonates, we measured
the expression of maturation markers (CD80 and CD86) on
CD11b+ mDCs. Wild-type neonates and adults or IL-4Ra2/2DC
neonates (IL-4Ra2/2DCNR) were infected with RSV, and the
expression of CD80 and CD86 was measured on pulmonary
CD11b+ mDCs at 14 d after infection by flow cytometry (Fig. 5).
Consistent with previous studies [18, 19], neonatal CD11b+
mDCs were less mature (i.e., reduced expression of CD80 and
CD86) compared with their adult counterparts during RSV
infection. In the absence of IL-4Ra, the expression of CD80
and CD86 was significantly enhanced on CD11b+ mDCs (IL-
4Ra2/2DCNR compared with neonatal mice infected with
RSV). These data suggest that elevated expression of IL-4Ra on
Figure 2. Deletion of IL-4Ra on CD11c+ cells attenuated Th2-biased immune responses upon RSV reinfection. IL-4Ra2/2DC or IL-4Ra2/loxDC
mice were infected at 5 d old and reinfected with RSV 4 wk later (IL-4Ra2/2DCRR and IL-4Ra2/loxDCRR, respectively). Control mice were
sham infected (IL-4Ra2/2DCsham and IL-4Ra2/loxDCsham). Pulmonary Th profile was measured via flow cytometry at 6 d after reinfection,
and virus gene expression was calculated via real-time RT-PCR at 4 d after primary infection. (A) Percentage (upper panel) and numbers
(middle panel) of pulmonary CD4+ T cells expressing IFN-g, IL-4, or both IFN-g and IL-4. The bottom panel displays representative flow plots.
(B) Relative expression of the RSV NS1 gene in the lung at 4 d after primary infection. Data are representative of 3 independent experiments
with 4–5 mice/group. *P , 0.05.
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neonatal CD11b+ mDCs suppresses the ability of those cells to
mature in response to RSV infection, resulting in a Th2-biased,
adaptive immune response.
Overexpression of IL-4Ra on adult CD11b+ mDCs
exacerbated Th2 responses to RSV infection in
adult mice
Expression of IL-4Ra on CD11b+ mDCs declines significantly
with age. To further confirm the pathogenic role of IL-4Ra, we
overexpressed IL-4Ra on adult mDCs. Specifically, we transduced
adult BMDCs with IL-4Ra (pLV-IL-4Ra-eGFP) or eGFP (pLV-
eGFP) expressing lentivirus. Successful transduction was verified
by flow cytometry (Supplemental Fig. 4). CD11b+ mDCs that
were positive for eGFP were then sorted and adoptively
transferred to the lungs of naı̈ve adult mice; 1 wk later, those
mice were infected with RSV. At 6 d after infection, we analyzed
pulmonary CD4+ T cell responses. Overexpression of IL-4Ra on
adult CD11b+ mDCs (pLV-IL-4Ra-eGFP) resulted in a lower
percentage but no significant change in the number of CD4+IFN-g+
T cells (Fig. 6A). A higher percentage and number of CD4+IL-4+
T cells were observed when IL-4Ra was overexpressed on adult
CD11b+ mDCs compared with the control groups (Fig. 6A and B).
There was no change in the percentage of CD4+IFN-g+IL-4+
cells with overexpression of IL-4Ra on adult CD11b+ mDCs, but
there was an increase in the number of those cells (Fig. 6B).
DISCUSSION
Infants are particularly vulnerable to severe RSV infection; both
human and animal studies implicate a Th2-biased immune
response in the pathogenesis of RSV in infants [5, 6, 9–11]. In
particular, single-nucleotide polymorphisms in the IL-4Ra gene
that increase the receptor response to its cytokines (IL-4 or IL-13)
are associated with increased IgE production, hospitalization
rates from RSV infection, and susceptibility to asthma [13, 29].
Pharmacologic down-regulation of IL-4Ra in the lung is pro-
tective against RSV disease in neonatal mice and is effective in
preventing Th2-biased immunopathogenesis [12]. In the current
study, we observed increased expression of IL-4Ra on pulmonary
CD11b+ mDCs in neonatal, compared with adult, mice. Deletion
of IL-4Ra on neonatal CD11c+ cells (including CD11b+ mDCs
and other cells) resulted in a significant reduction in Th2
polarization, RSV-associated airway hyperreactivity, inflamma-
tion, and eosinophilia after RSV reinfection in vivo. This was
Figure 3. Deletion of IL-4Ra on CD11c+ cells
protected mice from immunopathophysiology
upon RSV reinfection. IL-4Ra2/2DC or IL-4Ra2/loxDC
mice were infected and reinfected with RSV, as
previously described. BALF cellularity, airways
resistance in response to methacholine (MeCh)
challenge, and histology were performed at 6 d
after reinfection. (A) BALF cellularity. Macs,
macrophages; Lymph, lymphocytes; Neutro,
neutrophils; Eos, eosinophils. (B) Airway re-
sistance. (C) H&E-stained lung sections and
inflammation score. Arrowheads point to cellu-
lar infiltrates. (D) PAS-stained lung sections
and PAS score. Arrowheads point to mucus.
Scale bar, 400 mm in the upper panels. The
bottom panels are images taken under higher
magnification of the selected area in the upper
panel (inset box). Scale bar, 100 mm in the
bottom panels. Data are representative of 2
independent experiments with 4–5 mice/
group. *P , 0.05.
TABLE 1. Deletion of IL-4Ra on CD11c+ cells attenuated Th2-biased cytokine responses in the lung upon RSV reinfection
Cytokines IL-4Ra2/loxDCsham IL-4Ra2/2DCsham IL-4Ra2/loxDCRR IL-4Ra2/2DCRR
BALF (pg/ml)
IFN-g B.D. B.D. 51.9 6 15.9 88.9 6 14.4
IL-4 B.D. B.D. 1.1 6 0.2 1.2 6 0.2
IL-12p40 B.D. B.D. 9.2 6 3.4 21.0 6 4.3*
Lung homogenates (pg/ml)
IL-13 21.0 6 2.1 19.3 6 4.5 27.7 6 1.6† 18.9 6 2.1*
IL-4Ra2/loxDC or IL-4Ra2/2DC mice were infected at 5 d old and reinfected with RSV 4 wk later (IL-4Ra2/loxDCRR or IL-4Ra2/2DCRR, respectively).
Control mice received serum-free viral growth medium (IL-4Ra2/loxDCSham or IL-4Ra2/2DCSham). Cytokines were measured in BALF (IFN-g, IL-4, and
IL-12p40) or lung homogenates (IL-13) at 6 d after reinfection and are reported in picograms per milliliter. n = 4–5 mice/group. B.D., below the
detection limit. *P , 0.05 vs. IL-4Ra2/loxDCRR. †P , 0.05 vs. IL-4Ra2/loxDCSham or IL-4Ra2/2DCSham.
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accompanied by an increase in IL-12 production. In vitro
T cell–activation assays demonstrated the specificity of IL-4Ra on
neonatal CD11b+ mDCs in the induction of Th2 responses to
RSV. Because adult CD11b+ mDCs express significantly less
IL-4Ra, complimentary experiments in which adult CD11b+
mDCs were made to overexpress IL-4Ra were also performed.
Overexpression of IL-4Ra on adult CD11b+ mDCs with the
transfer of those cells into the lungs of adult mice before RSV
infection was able to recapitulate the Th2-biased immunopatho-
genesis observed in neonatal mice. Mechanistically, we demon-
strated that pulmonary CD11b+ mDCs were less mature in
neonates compared with adults in response to RSV infection and
that deletion of IL-4Ra on CD11b+ mDCs enhanced their
maturation, altering Th2/Th1 immune responses to RSV.
The maturation status of DCs is important to their function,
and the costimulatory molecules CD80 and CD86 are thought
to be essential as a second signal for T cell activation. Here, we
demonstrated that the levels of CD80 and CD86 on CD11b+
mDCs were associated with the axis of CD4+ T cell differenti-
ation (i.e., Th1 vs. Th2). Neonatal CD11b+ mDCs expressed
less CD80 and CD86 than their adult counterparts did (Fig. 5)
and induced fewer Th1 cells in response to RSV infection [9].
Interestingly, CD103+ mDCs, which mainly activate CD8+
T cells, have also been shown to be immature in neonates
compared with adults, and the maturation status of CD103+
mDCs influences the epitope hierarchy of CD8+ T cells in
response to RSV infection [30]. Thus, it is exciting to speculate
that maturation status of CD11b+ mDCs may also dictate epitope
hierarchy of CD4+ T cells in response to RSV infection—a concept
that we are currently exploring. We further demonstrated that the
expression of CD80 and CD86 on CD11b+ mDCs was partially
regulated by the expression of IL-4Ra because deletion of IL-4Ra
on CD11b+ mDCs restored some expression of CD80 and CD86
after RSV infection. The mechanism or mechanisms by which IL-
4Ra is developmentally regulated and how IL-4Ra regulates the
expression of CD80 and CD86 are currently unclear and warrant
further investigation.
The ratio of Th2/Th1 cells decreased by 50% in the IL-4Ra2/2DC
mice compared with IL-4Ra2/loxDC mice both in vivo and in vitro
(Fig. 2 and 4). Although the reduction was not massive, it was
significant. The reduction in Th2/Th1 ratio was accompanied by
improved lung function and significantly decreased lung
pathologies. We observed this phenomenon in our previous
publication [12]. A subtle reduction in IL-4Ra on Th cells and
DCs significantly improved lung pathology and abolished lung
dysfunction after RSV reinfection. Our data indicate that the
pathophysiology is determined by the balance of Th1/Th2
immune responses and that a small shift from the Th2-biased
immune response is all that is necessary to improve lung
pathophysiology.
As with our previous studies [9, 12], we observed a CD4+ T cell
population expressing both IFN-g+ and IL-4+ after RSV re-
infection. Initially, those cells were thought to be pre-Th1/Th2
cells that were in the intermediate stage during the commitment
process of Th1/Th2 cells [31, 32]. However, recent data
Figure 5. Loss of IL-4Ra on CD11b+ mDCs enhanced their maturation
response to RSV. Neonatal or adult wild-type mice and neonatal IL-
4Ra2/2DC mice were infected with RSV. Maturation markers (CD80
and CD86) and MHC-II were measured on lung CD11b+ mDCs via flow
cytometry. (A) MFI of CD80 on CD11b+ mDCs. (B) MFI of CD86 on
CD11b+ mDCs. (C) MFI of MHCII on CD11b+ mDCs. Data are
representative of 3 independent experiments with 4–5 mice/group.
*P , 0.05.
Figure 4. Absence of IL-4Ra on CD11b+ mDCs dampened Th2
responses to RSV infection in vitro. Neonatal IL-4Ra2/2DC and IL-
4Ra2/loxDC were infected with RSV. CD11b+ mDCs were isolated from
those mice at 6 d after infection and cultured with CD4+ T cells
purified from the spleens of naı̈ve, adult BALB/c mice. Th profile was
measured after 72 h coculture using flow cytometry. (A) Percentage of
pulmonary CD4+ T cells expressing IFN-g. (B) Percentage of pulmo-
nary CD4+ T cells expressing IL-4. (C) Ratio of pulmonary CD4+ T cells
expressing IL-4 and IFN-g. Data are representative of 2 independent
experiments with 3 samples/group. *P , 0.05.
Shrestha et al. IL-4Ra on dendritic cells in RSV infection
www.jleukbio.org Volume 102, July 2017 Journal of Leukocyte Biology 159
demonstrate that this phenotype is acquired after full differen-
tiation and that these cells support both type 1 and type 2
inflammatory responses [33]. IL-4Ra deletion on CD11b+ mDCs
decreased the percentage of those cells in the lungs of mice after
RSV reinfection. The exact role of those cells in RSV pathogenesis
remains elusive, but the reduction of those cells has consistently
coincided with reduced pulmonary immunopathophysiology
upon RSV reinfection here and in our previously published
work [9, 12].
Although deletion of IL-4Ra on CD11b+ mDCs did not alter
the percentage of pulmonary Th1 (CD4+ IFN-g+) cells after RSV
reinfection, there was an increase in the level of IL-12p40 (a Th1
cytokine) in the BALF (Table 1). The elevated IL-12 (p40) level
may result from the decreased IL-13 because IL-13 has been
previously shown to inhibit IL-12 production via IL-4Ra
signaling [34].
A limitation of our in vivo studies was that IL-4Ra was not
specifically deleted on CD11b+ mDCs. In fact, IL-4Ra was deleted
on CD11c+/hi cells, including AMs, CD11b+ mDCs, and CD103+
mDCs, and on CD11c+/lo cells, including pDCs, NK cells, B cells,
and CD8+ T cells [35]. However, our in vitro data (T cell
activation assays with neonatal CD11b+ mDCs), our in vivo data
(adoptive transfer of adult CD11b+ mDCs that overexpress IL-
4Ra), and data from the literature (summarized below) argue for
the specific role of IL-4Ra on CD11b+ mDCs in RSV immuno-
pathogenesis. IL-4Ra was deleted on CD103+ mDCs in our
model; however, we speculated that the deletion of IL-4Ra
on CD103+ mDCs most likely has minimal effect on the
Th2-biased response to RSV infection for the following reasons.
CD103+ mDCs mainly activate CD8+, not CD4+, T cells [16, 17].
Additionally, neonatal CD103+ mDCs express significantly less IL-
4Ra compared with their adult counterparts, whereas the Th2
bias is only observed in neonates. In the Cryptococcus-infection
model, deletion of IL-4Ra specifically on AMs (LysMCreIL-4Ra2/lox)
was unable to alter the Th2 responses [36], suggesting that IL-
4Ra expression on AMs has no effect on Th2 polarization. As to
the cells expressing low levels of CD11c, we and others [24] have
observed an inefficient Cre function and, thus, inefficient
deletion of IL-4Ra in those cells, including B [24] and T cells
(Supplemental Fig. 2).
In summary, we have demonstrated a novel, age-dependent
mechanism (IL-4Ra on CD11b+ mDCs) responsible for the
Th2-biased immunopathogenesis during neonatal RSV infection.
We have shown that IL-4Ra expression on CD11b+ mDCs is
developmentally regulated, and greater expression of IL-4Ra is
associated with a less-mature phenotype of the CD11b+ mDCs in
response to RSV infection, resulting in Th2-biased immune
responses. The deletion of IL-4Ra on CD11b+ mDCs significantly
decreased the Th2-biased immunopathogenesis during RSV
infection by allowing enhanced maturation of CD11b+ mDCs.
Our data suggest that modulating IL-4Ra signaling on CD11b+
mDCs may be a strategy for developing RSV therapeutics and
that vaccine strategies should investigate such signaling in
determining efficacy.
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